0001782250-24-000002.txt : 20240502 0001782250-24-000002.hdr.sgml : 20240502 20240502102317 ACCESSION NUMBER: 0001782250-24-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 EFFECTIVENESS DATE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lucy Therapeutics, Inc. CENTRAL INDEX KEY: 0001782250 ORGANIZATION NAME: IRS NUMBER: 822363951 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-500678 FILM NUMBER: 24906061 BUSINESS ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-249-4812 MAIL ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0708 D/A LIVE 0001782250 Lucy Therapeutics, Inc. 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 617-249-4812 DELAWARE None None Corporation true Amy Ripka 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Executive Officer Director Rachel Sha 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Director John Ripple 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Director Robert Michael Poole 21 Hickory Drive, Suite 2B Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b true 0001782250-23-000002 2023-12-15 false true true false 0 10552797 10552797 0 false 6 0 0 0 false Lucy Therapeutics, Inc. /s/ Amy Ripka Amy Ripka President 2024-05-02